On-Target Anti-TGF-beta Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
Adilson Fonseca Teixeira, Peter ten Dijke, Hong-Jian Zhu
Frontiers in Cell and Developmental Biology | FRONTIERS MEDIA SA | Published : 2020
Research on TGF-b signaling in our laboratories were funded by the Australia's National Health and Medical Research Council (NHMRC), Friends of the Royal Melbourne Hospital Neurosciences Foundation (H-JZ), and the Cancer Genomics Centre Netherlands (CGC.NL) (PD). AT was supported by the Melbourne Research Scholarship.